Brokerages Set Alpine Immune Sciences, Inc. (NASDAQ:ALPN) PT at $38.86

Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) have earned a consensus recommendation of “Buy” from the seven analysts that are currently covering the stock, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating. The average 12-month target price among brokerages that have covered the stock in the […]

Related Keywords

Switzerland ,Swiss , ,Morgan Stanley ,Schonfeld Strategic Advisors ,Analyst Recommendations For Alpine Immune Sciences ,Alpine Immune Sciences Inc ,Alpine Immune Sciences Stock Down ,News Ratings For Alpine Immune Sciences Daily ,Nan Fung Group Holdings Ltd ,Alpine Immune Sciences ,Nasdaq ,Wolfe Research ,Walleye Capital ,Swiss National Bank ,Get Free Report ,Fung Group Holdings Ltd ,Strategic Advisors ,Capital Management ,Immune Sciences Stock Down ,Immune Sciences ,Get Free ,Alpine Immune Sciences Daily ,Nasdaq Alpn ,Alpn ,Medical ,Ratings ,Consensus ,